B+
Bull case
20%
Probability
Target price
$18.00
Analysis reference price unavailable
Analysis 2026-10-16 · RankAlpha Sentiment Codex
CC
ChemoursCNYSE / Materials
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
45%
Probability
Target price
$13.00
Analysis reference price unavailable
Analysis 2026-10-16 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$9.00
Analysis reference price unavailable
Analysis 2026-10-16 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-10-16
Recent news sentiment (30D)
+20.2
Positive
Company
-
Unavailable
Macro
+20.2
Positive
Pulse
-
Unavailable
Weekly research (10D)
+26.0
Positive
Sentiment proxy
+55.6
Score
AI commentary
Recent verified news is mixed but has turned more cautious: the September settlement reduced a defined legal exposure, while RBC's October downgrade and target cut emphasized weak TiO2 demand. A reported 2.5% October 13 premarket decline followed the downgrade, but no sustained-reaction series was verified. Settlement filing Downgrade coverage No usable social, options, short-interest or employee-sentiment measurements were supplied; zeros above denote unavailable data, not neutral readings.
RankAlpha Sentiment Codex - 2026-10-16
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-09-10eventNorth Carolina PFAS settlement reduces a defined liabilityMedium impact
The September agreement provides for $455 million of payments over 15 years, with Chemours responsible for 50%. It resolves specified claims but remains subject to dismissal orders; it does not eliminate broader PFAS exposure. [#8-K-2026-09-10] SEC filing
2026-11-05eventQ3 results will test weaker-demand guidanceHigh impact
Chemours guided Q3 adjusted EBITDA to $175 million–$205 million and sequential sales to decline 5% to flat, citing weaker Opteon refrigerant demand. The next earnings date is estimated, not company-confirmed. [#SEC-8K-2026-08-04] Chemours Q2 release
2027-06-30catalystCash generation and TiO2 pricing must offset leverage and volume pressureHigh impact
Q2 free cash flow rose to $114 million and net leverage fell to 4.4x, while Chemours reported an approximately 5% year-to-date TiO2 price increase. Sustained debt reduction depends on those gains holding against weak demand. [#SEC-8K-2026-08-04] SEC earnings exhibit
Recommendation
N/A
No formal recommendation provided.
As of 2026-10-16 • Updated nightlySource: Internal modelMethodology